Ideas to Action:

Independent research for global prosperity

CGD Policy Blogs

 

Not Yet Breathing Easy About TB

Pop quiz: What disease killed John Keats at age 26, John Harvard at 30, Simon Bolivar at 47, Puccini's Mimi right after "Sono Andati?" - and now kills 4,400 people every day, most in the prime of their lives? Answer: TB, an ancient scourge whose current manifestations demonstrate both the highs and the lows of global public health.

Beating the Market

The vaccine industry is looking healthier and happier than it has in years, according to The Economist, thanks to the combination of new science, new money and new recognition of the value of prevention. The advances in adjuvants - ingredients in vaccines that make the antigens go further and work better - and new ways to deliver vaccines without needles, such as nasal sprays mean that genuine innovations are hitting the market.

Funding the Global Fund: Passing the $10B mark and Beyond

Perhaps as a build up to the Global Fund's second replenishment process, which is in full swing in Oslo this week, there has been quite a buzz about new money for the Global Fund moving its assets to over 10 billion dollars. Two weeks ago, the Global Fund announced that with its newly pledged historic contribution of US$724 million for FY07, the United States contributions and commitments now total at US$3 billion, which constitutes 29% of all paid in contributions and firm pledges. Japan has also stepped up to the plate with a recent contribution: